Volume 5 - Science, Mycotoxins & Why Treatment Fails

Why do people remain unwell even after treatment, remediation or environmental clearance?

In Science, Mycotoxins & Why Treatment Fails, Jeff Charlton examines the scientific, environmental and systemic reasons why recovery can stall when the true source of exposure has not been properly identified or removed.

This fifth volume of the Building Forensics Legacy Series explores how mycotoxins, contaminated dust, microbial fragments, Actinobacteria, endotoxins and other airborne hazards can remain active long after visible mould has been treated.

It also looks at why conventional investigations can fail, particularly when they are shaped by limited budgets, narrow testing scopes, short-term procurement decisions or professionals whose training exceeds their real-world competence.

Inside this volume

• Airborne mycotoxins and hidden exposure pathways
• Pollen as a carrier for spores, toxins and microbial contaminants
• The difference between training, certification and genuine competence
• Why low-cost procurement can lead to under-investigation
• Clearance and verification failures
• Why decontamination may worsen exposure
• The role of contaminated dust and hidden reservoirs
• Medical and international case studies
• Why treatment fails when environmental exposure continues
• Recovery, re-entry and the importance of sustained exposure reduction
• A 50-year environmental hazard timeline
• The impact of airtight buildings, poor ventilation and modern materials

The book challenges the assumption that a certificate or completed remediation automatically proves that a property is safe. It explains why visible improvement can exist alongside continued exposure and why environmental risk must be assessed through science, evidence and real-world outcomes.

A central message of the volume is that medical treatment cannot deliver lasting recovery while the patient continues to encounter the same environmental trigger. Recovery depends on meaningful exposure reduction, cautious reoccupation, environmental monitoring and realistic expectations.

Written for

Housing providers, environmental health professionals, insurers, clinicians, remediation contractors, landlords, legal teams, policymakers, investigators and individuals affected by suspected building-related illness.